Netflix Inc. (NFLX) Pops 2.6% for January 19

Equities Staff  |

One of the S&P 500’s big winners for Tuesday January 19 was Netflix Inc. (NFLX) as the company’s stock climbed 2.6% to $106.75 on volume of 24.32 million shares.

The stock opened at $106.57 and saw an intraday low of $105.55 and an intraday high of $110.14. All told, the day saw a per-share gain of $2.71. The stock’s average daily volume of 18.22 million and 427.39 million shares outstanding. Netflix Inc. now has a 50-day SMA is $117.66 and 200-day SMA is $102.55, and it has a 52-week high of $133.27 and a 52-week low of $47.71.

Netflix Inc operates as an Internet television network providing TV shows & movies which include original series, documentaries & feature films. The Company has three segments namely Domestic streaming, International streaming & Domestic DVD.

Based out of Los Gatos, CA, Netflix Inc. has 2,450 employees and, after today’s trading, reached a market cap of $45.62 billion. The stock’s P/E Ratio is 275.9. Its P/S ratio is 8.97, P/B ratio is 21.06, and P/FCF ratio is -69.5.

For a complete fundamental analysis analysis of Netflix Inc., check out’s Stock Valuation Analysis report for NFLX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Level Headed at World Crypto Con - Steve Beauregard CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Q BioMed Inc

Q BioMed Inc is a biomedical acceleration and development company. The company is a biomedical acceleration and development company focused on licensing, acquiring and providing strategic resources to life sciences…